Articles

State-of-the-Art

10.4244/EIJ-D-25-00116 Dec 15, 2025
Transcatheter edge-to-edge repair in secondary mitral regurgitation
Rodés-Cabau J, Mengi S, Salaun E, Paradis J, Abraham W
free

Original Research

10.4244/EIJ-D-25-00757 Dec 15, 2025
Watchman FLX versus Watchman 2.5 for left atrial appendage closure: a propensity score-matched analysis
Galea R, La Fazia V, Della Rocca D, Gasys A, Bini T, Siontis G, Gianni C, Roten L, Mohanty S, Brugger N, Torlapati P, Horton R, Al-Ahmad A, Biase L, Natale A, Räber L

Original Research

10.4244/EIJ-D-25-00489 Dec 15, 2025
Predictors of underexpansion after transcatheter aortic valve implantation with the ACURATE neo valve
Alvarez-Covarrubias H, Taniguchi Y, Jurisic M, Altaner N, Syryca F, Blum E, Pellegrini C, Duesmann C, Mayr N, Rheude T, Schunkert H, Kastrati A, Cassese S, Xhepa E, Joner M

Original Research

10.4244/EIJ-D-24-01168 Dec 15, 2025
Feasibility of valve-in-root transcatheter aortic valve implantation in patients with prior aortic root replacement and repair
Zientara A, Brizzi F, von zur Mühlen C, Bruijnen H, Kreibich M, Berger T, Kondov S, Siepe M, Rylski B, Benk J, Beyersdorf F, Rilinger J, Maier A, Oettinger V, Westermann D, Czerny M, Gottardi R

Research Correspondence

10.4244/EIJ-D-25-00319 Dec 15, 2025
Phenotyping coronary microvascular dysfunction endotypes using invasive exercise stress testing
Rahoual G, Procopi N, Beaupré F, Michon M, Martinez C, Guedeney P, Hammoudi N, Hatem S, Vicaut E, Kerneis M, Silvain J, Montalescot G, Zeitouni M, of the ACTION Study Group o

Research Correspondence

10.4244/EIJ-D-25-00667 Dec 15, 2025
Dual-therapy CD34 antibody-covered sirolimus-eluting COMBO stents versus sirolimus-eluting Orsiro stents in percutaneous coronary intervention: five-year outcomes of the SORT OUT X randomised clinical trial
Jakobsen L, Christiansen E, Frøslev T, Raungaard B, Lassen J, Eftekhari A, Jensen L

Research Correspondence

10.4244/EIJ-D-25-00482 Dec 15, 2025
Efficacy of ultrasound renal denervation adjusted for changes in detected antihypertensive medications in the RADIANCE-HTN TRIO Study
Zeijen V, Azizi M, Kirtane A, McClure C, Kably B, Daemen J
open access

Letter to the editor

10.4244/EIJ-D-25-00868 Dec 15, 2025
Letter: Balancing, timing, and efficiency in tricuspid TEER
Ktenopoulos N, Apostolos A, Toutouzas K
free

Reply to the letter to the editor

10.4244/EIJ-D-25-00944 Dec 15, 2025
Reply: Balancing, timing, and efficiency in tricuspid TEER
Baldus S, Lurz P, of the TriCLASP study investigators o
free

Editorial

10.4244/EIJ-E-25-00050 Dec 1, 2025
Beta blockers after MI: safe for the few, still relevant for the many
Silvain J, Procopi N
free

Editorial

10.4244/EIJ-E-25-00049 Dec 1, 2025
Do we still need more data to adopt a short duration of DAPT routinely following PCI in high bleeding risk patients?
Marquis-Gravel G, Lopes R
free

State-of-the-Art

10.4244/EIJ-D-25-00100 Dec 1, 2025
Diagnosis, risk stratification, and early management of non-ST-segment elevation acute coronary syndrome
Kovacevic M, Jones D, Thiele H, Steg P, Kunadian V
free

State-of-the-Art

10.4244/EIJ-D-25-00296 Dec 1, 2025
Identification and treatment of calcified nodules in percutaneous coronary intervention
Ali Z, Spratt J, Finn A, Maehara A, Shin D
free
Receive our newsletter


PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved